|Articles|July 2, 2023
- Pharmaceutical Executive: July 2023
- Volume 43
- Issue 7
Pharmaceutical Executive, July 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
Crossing the Brain Barrieralmost 3 years ago
Biotech’s Survival Story: Companies Bear Down for Lean Yearsalmost 3 years ago
Harnessing AI for Pharma Salesalmost 3 years ago
Tapping New and Improved Drug Innovations in Asiaalmost 3 years ago
Drug Shortages Continue to Plague FDA, Manufacturersalmost 3 years ago
Contrasting Aims Highlight Pharma Reform Pursuitsalmost 3 years ago
Shifting Macro Trends Offer Hope for Biotech Performance Boostalmost 3 years ago
‘Bolus’ Markets: Unique Business Opportunities with Promise and RiskAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
2
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
3
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
4
FDA's Timeline for DTC Prescription Drug Ad Oversight
5

